RxDoctor Payments Data

Robin Loveday

Nurse Practitioner · Knoxville, TNNPI 1194003301

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $50,480 of the $56,082 with a category attached, or 90.0%. Novo Nordisk accounts for 91.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $55,943 and has fallen 99.9% since, to $56 in 2023. Among nurse practitioner clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,082in general payments, 2019–2025

Across 161 payments — averaging $348.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$51K
  • Medtronic$4K
  • Abbott$361
  • Dexcom, Inc.$155
  • Lilly USA, LLC$86
  • Amgen$82
  • plus $522 from 18 others

What the payments were for

  • Speaking & faculty fees$50,48090%
  • Travel & lodging$2,9275%
  • Food & beverage$2,4254%
  • Education$2500%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,082 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Other nurse practitioner in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →